Research of Intensive Treatment in Hormone Receptor<10% and Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer Patients With Positive Lymph Node Residual Disease After Neoadjuvant Chemotherapy
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Primary Breast Cancer
Interventions: DRUG: Vinorelbine
Sponsor: Tao OUYANG